Premium
Rezolute Inc (RZLT)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the t... Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.97 | 29.6636085627 | 3.27 | 4.705 | 3.19 | 3444368 | 4.14580177 | CS |
| 4 | 1.15 | 37.216828479 | 3.09 | 4.705 | 2.83 | 1733597 | 3.72326416 | CS |
| 12 | 1.18 | 38.5620915033 | 3.06 | 4.705 | 2.29 | 2086892 | 3.22844405 | CS |
| 26 | -5.5 | -56.4681724846 | 9.74 | 11.165 | 1.07 | 4477806 | 2.56174155 | CS |
| 52 | -0.01 | -0.235294117647 | 4.25 | 11.4565 | 1.07 | 2855461 | 3.69816825 | CS |
| 156 | 2.2 | 107.843137255 | 2.04 | 11.4565 | 0.72 | 1215872 | 3.69885869 | CS |
| 260 | -9.23 | -68.5226429102 | 13.47 | 17.39 | 0.72 | 756840 | 3.71145122 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
